Trial intelligence / Profile preview

Cethromycin vs Clarithromycin in Community-Acquired Pneumonia

NCT00336505Phase 3Completed

Sponsor
Advanced Life Sciences Holdings
Start
Dec 2005
Primary completion
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of cethromycin in community acquired pneumonia (CAP), sponsored by Advanced Life Sciences Holdings. Started Dec 2005; status: completed.

02

Drugs

cethromycin
03

Conditions

community acquired pneumonia (CAP)

Beyond the preview

Go deeper on NCT00336505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00336505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call